APOH and autoimmune polyendocrinopathy: If verified in larger cohorts of patients, domain specific anti-B2GPI antibodies could potentially help stratify patients with a higher risk of APS in association with systemic autoimmune disease which might inform clinical decisions such as when to offer anticoagulant prophylaxis.